To ensure speedy trials of the cases, these cases will be filed before designated/special courts set up for the purposes of drugs related issues as per the provisions of the Drugs and Cosmetics (Amendment) Act, 2008.

Special instructions will be given to the drug testing laboratories to send their reports at the earliest, within the minimum time possible, so that the matter is disposed of expeditiously.

The Drug Controller General (India) along with other officials will be the nodal authority who will inter alia oversee the functioning of the reward scheme.

The zonal and sub-zonal officers of the CDSCO will act as nodal officers to whom the whistle blower / informer can provide the information about the manufacture / movement of spurious / adulterated drugs.

The identity of the whistle blower / informer will be kept secret and will be known only to the concerned zonal and sub-zonal officers of the CDSCO, the DCG(I) and the Director General Health Services. It will be the responsibility of the concerned officials to keep the details of the whistle blower / informer secret.

The identity of the whistle blower / informer will not be disclosed to the committee.